Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data (Q34240937)

31 July 2017

Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data (English)

1 reference

31 July 2017

0 references

1 reference

James M Oleske

12

0 references

Scott A Halperin

5

object named as

Scott A Halperin

1 reference

31 July 2017

3

Anna Taddio

1 reference

31 July 2017

Jane F Gidudu

1

1 reference

31 July 2017

Gary A Walco

2

1 reference

31 July 2017

William T Zempsky

4

1 reference

31 July 2017

Angela Calugar

6

1 reference

31 July 2017

Neville A Gibbs

7

1 reference

31 July 2017

Renald Hennig

8

1 reference

31 July 2017

Milivoj Jovancevic

9

1 reference

31 July 2017

Eva Netterlid

10

1 reference

31 July 2017

Terri O'Connor

11

1 reference

31 July 2017

Frederick Varricchio

13

1 reference

31 July 2017

Theodore F Tsai

14

1 reference

31 July 2017

Harry Seifert

15

1 reference

31 July 2017

Anne E Schuind

16

1 reference

31 July 2017

Brighton Immunization Site Pain Working Group

17

1 reference

31 July 2017

language of work or name

English

0 references

publication date

18 April 2012

1 reference

31 July 2017

1 reference

31 July 2017

30

1 reference

31 July 2017

4558-4577

1 reference

31 July 2017

30

1 reference

Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Management of injection pain in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Low immunisation uptake: is the process the problem?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Self-assessment of immediate post-vaccination pain after two different MMR vaccines administered as a second dose in 4- to 6-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Pain and measles, mumps, and rubella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

The development of standardized case definitions and guidelines for adverse events following immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Injection site and risk of medically attended local reactions to acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Shoulder injury related to vaccine administration (SIRVA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Needle pain in children: contextual factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Association between self-report pain ratings of child and parent, child and nurse and parent and nurse dyads: meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Pain in 4- to 6-year-old children receiving intramuscular injections: a comparison of the Faces Pain Scale with other self-report and behavioral measures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Taking the "ouch" out of injections for children. Using distraction to decrease pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Self-reports of pain intensity and direct observations of pain behavior: when are they correlated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Summary proceedings from the neonatal pain-control group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Fetal pain: a systematic multidisciplinary review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Pain, hurt, and harm. The ethics of pain control in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline (summary).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Routine immunization practices: use of topical anesthetics and oral analgesics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Mothers' beliefs about analgesia during childhood immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: systematic review and meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Assessment of acute pain and anxiety in children and adolescents by self-reports, observer reports, and a behavior checklist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Measurement of pain in children with self-reporting and behavioral assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

A comparison of three ways of measuring pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

An assessment of children's pain: a review of behavioral, physiological and direct scaling techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

An intrusive impact of anchors in children's faces pain scales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Developmental differences in children's use of rating scales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

A comparison of faces scales for the measurement of pediatric pain: children's and parents' ratings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Use of lidocaine-prilocaine cream for vaccination pain in infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

A revised measure of acute pain in infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Making vaccines more acceptable--methods to prevent and minimize pain and other common adverse events associated with vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Predicting maternal and behavioral measures of infant pain: the relative contribution of maternal factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Validation and properties of the verbal numeric scale in children with acute pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Evidence for the use of a numerical rating scale to assess the intensity of pediatric pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children's self-reports of pain intensity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Treating Children with HIV Infection: What We Can Do, We Should Do

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.085

10.1016/J.VACCINE.2012.03.085

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference